Mamucan, Loreto P.
HRN: 27-35-53 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CEFTAZIDIME 1GM (VIAL)
06/20/2025
06/26/2025
IV
1g
Q8h
CAP-MR
Checking Initial Appropriateness
06/20/2025
AZITHROMYCIN 500MG TABLET (TAB)
06/20/2025
06/24/2025
PO
500mg
Od
Cap-Mr
Checking Initial Appropriateness